Bioinformatic Analysis of GCN1 as a Novel Diagnostic and Prognostic Biomarker in Hepatocellular Carcinoma and Preliminary Exploration of Its Molecular Mechanisms
Figure 1.
GCN1 Expression in Hepatocellular Carcinoma Tissues Versus Normal Tissues and Its Diagnostic Efficacy. A. GCN1 gene expression levels in the TCGA-LIHC cohort show significantly higher expression in tumor tissues compared to normal tissues (P < 0.001). B. In paired samples from the TCGA-LIHC cohort, tumor tissues also exhibited significantly higher GCN1 expression than adjacent non-tumorous tissues (P < 0.001). C. The ROC curve evaluated the ability of GCN1 to distinguish tumor tissues from normal tissues in the TCGA-LIHC cohort.